Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced that Peter Suzdak, PhD, the Company’s Chief Executive Officer and Ted Jeong, Chief Financial Officer, will present at the 26th Annual ROTH Conference on Tuesday, March 11, 2014 at 2:00 p.m. Pacific Time. The conference takes place at The Ritz-Carlton in Dana Point, California. A webcast of the presentation will be available on www.rexahn.com.
Help employers find you! Check out all the jobs and post your resume.
